Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Front Pediatr ; 11: 981880, 2023.
Article in English | MEDLINE | ID: covidwho-2257555

ABSTRACT

Introduction: Multisystem inflammatory syndrome in children (MIS-C) is believed to be one of the most important life-threatening complications of COVID-19 infection among children. In any setting, early recognition, investigations, and management of MIS-C is crucial, but it is particularly difficult in resource-limited settings (RLS). This is the first case report of MIS-C in Lao People's Democratic Republic (Lao PDR) that was promptly recognized, treated, and resulted in full recovery with no known complications despite the resource limitations. Case presentation: A healthy 9-year-old boy presented to a central teaching hospital fulfilling the World Health's Organization's MIS-C criteria. The patient had never received a COVID-19 vaccine and had a history of COVID-19 contact. The diagnosis was based upon the history, changes in the patient's clinical status, and response to treatment and negative testing and response to treatment for alternative diagnoses. Despite management challenges relating to limited access to an intensive care bed and the high cost of IVIG; the patient received a full course of treatment and appropriate follow-up cares post discharge. There were several aspects to this case that may not hold true for other children in Lao PDR. First, the family lived in the capital city, close to the central hospitals. Second, the family was able to afford repeated visits to private clinics, and the cost of IVIG, and other treatments. Third, the physicians involved in his care promptly recognized a new diagnosis. Conclusions: MIS-C is a rare but life-threatening complication of COVID-19 infection among children. The management of MIS-C requires early recognition, investigations, and interventions which may be difficult to access, cost-prohibitive, and further increase demand on healthcare services that are already limited in RLS. Nevertheless, clinicians must consider means for improving access, determine which tests and interventions are worth the cost, and establishing local clinical guidelines for working within resource constraints while awaiting additional assistance from local and international public health systems. Additionally, using COVID-19 vaccination to prevent MIS-C and its complication for children may be cost-effective.

2.
Journal of Economic Studies ; 49(3):435-452, 2022.
Article in English | ProQuest Central | ID: covidwho-1764763

ABSTRACT

Purpose>This paper aims to assess whether the coronavirus disease 2019 (COVID-19) pandemic has encouraged governments to take actions towards fostering digital means of payments and financial transactions to stimulate economic activities and achieve higher financial inclusion.Design/methodology/approach>Using a logit model, this paper tests the impact of the level of income and GDP per capita, government effectiveness, digital adoption, number of commercial banks and the pandemic-related closure of business and stores due to full lockdowns on governments’ policy response regarding digital means of payments.Findings>The author finds that low- and lower-middle-income countries had significantly responded to the surged need for digital means of payment during the pandemic compared to the upper-middle-income and high-income countries. The author also finds that government effectiveness and the number of commercial banks were predictors of government policy response, while the full lockdown of countries and the overall digital adoption were not.Research limitations/implications>Data of the post-COVID-19 pandemic are limited, and the sample size is small.Originality/value>This is the first paper to empirically model governments' response during the pandemic to promote digital means of payments. This paper gives insight into post-crisis potential changes in digital payment adoption in the upcoming years.

3.
Vaccines (Basel) ; 10(3)2022 Mar 11.
Article in English | MEDLINE | ID: covidwho-1742748

ABSTRACT

Widespread vaccination against COVID-19 is critical for controlling the pandemic. Despite the development of safe and efficacious vaccinations, low-and lower-middle income countries (LMICs) continue to encounter barriers to care owing to inequitable access and vaccine apprehension. This study aimed to summarize the available data on COVID-19 vaccine acceptance rates and factors associated with acceptance in LMICs. A comprehensive search was performed in PubMed, Scopus, and Web of Science from inception through August 2021. Quality assessments of the included studies were carried out using the eight-item Joanna Briggs Institute Critical Appraisal tool for cross-sectional studies. We performed a meta-analysis to estimate pooled acceptance rates with 95% confidence intervals (CI). A total of 36 studies met the inclusion criteria and were included in the review. A total of 83,867 respondents from 33 countries were studied. Most of the studies were conducted in India (n = 9), Egypt (n = 6), Bangladesh (n = 4), or Nigeria (n = 4). The pooled-effect size of the COVID-19 vaccine acceptance rate was 58.5% (95% CI: 46.9, 69.7, I2 = 100%, 33 studies) and the pooled vaccine hesitancy rate was 38.2% (95% CI: 27.2-49.7, I2 = 100%, 32 studies). In country-specific sub-group analyses, India showed the highest rates of vaccine acceptancy (76.7%, 95% CI: 65.8-84.9%, I2= 98%), while Egypt showed the lowest rates of vaccine acceptancy (42.6%, 95% CI: 16.6-73.5%, I2= 98%). Being male and perceiving risk of COVID-19 infection were predictors for willingness to accept the vaccine. Increasing vaccine acceptance rates in the global south should be prioritized to advance global vaccination coverage.

4.
Front Glob Womens Health ; 1: 591809, 2020.
Article in English | MEDLINE | ID: covidwho-1533646

ABSTRACT

The coronavirus disease 2019 (COVID-19) is still unfolding. Its several implications are visible, yet more of them we have to observe and witness in future. Dealing with these impacts, this rapid-response article aims to situate the COVID-19 pandemic within Pakistan's overall sociocultural and politico-economic context; next to investigate the impacts of COVID-19 particularly the psychological ones on pregnant women in Pakistan via five case. One case history of Haleema (pseudonym) revealed how the pandemic exerted a substantial amount of mental pressure due to "arranging someone to accompany her to the hospital, finding a blood donor for her, and insecurity of convenience to hospital." In this article, we show that Pakistan's geographical division into urban with an appropriate healthcare system, infrastructure and economic status, and more impoverished rural areas may show different impacts on people in general and the pregnant women in particular. This difference of facilities may contribute to disease transmission in the more deprived areas, that also due to cultural norms and mores such as shaking hands, cheek-kissing, and hugging that spread the virus are being overturned and that pregnant women are particularly vulnerable to psychological effects of the pandemic.

5.
Front Public Health ; 8: 548708, 2020.
Article in English | MEDLINE | ID: covidwho-983737

ABSTRACT

The COVID-19 outbreak was declared by the World Health Organization (WHO) as global pandemic in March 2020. Considering the necessity to implement rapid response to control the pandemic and the fragility and the state of need of low income countries, it will be mandatory to develop a global approach in order to reduce the spread of infection and the creation of community viral reservoirs. So far, we could hypothesize a worst case scenario in which when the COVID-19 outbreak hits a peak in Africa and in low-income countries, the majority of such countries will be unprepared, with low resources allocated for affording the viral emergency and the consequences will be catastrophic with no lesson learnt. In the best case scenario, the COVID-19 will not affect Africa or South America on a large scale and, if the prevention measures will be implemented, we could register a lower incidence of hygiene linked diseases that still represent leading causes of death.


Subject(s)
COVID-19/epidemiology , COVID-19/prevention & control , Developing Countries/statistics & numerical data , Disease Outbreaks/prevention & control , Disease Outbreaks/statistics & numerical data , Health Policy , Public Health/statistics & numerical data , Africa , Humans , Incidence , SARS-CoV-2 , South America
SELECTION OF CITATIONS
SEARCH DETAIL